Cynosure Upgraded to “Buy” at TheStreet (CYNO)
Cynosure (NASDAQ:CYNO) was upgraded by equities researchers at TheStreet from a “hold” rating to a “buy” rating in a research report issued on Friday, Stock Ratings News reports.
The analysts wrote, “Cynosure Inc. Class A (CYNO) has been upgraded by TheStreet Ratings from hold to buy. The company’s strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in net income, growth in earnings per share and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity.”
A number of other firms have also recently commented on CYNO. Analysts at Griffin Securities initiated coverage on shares of Cynosure in a research note on Monday. They set a “buy” rating on the stock. Separately, analysts at Zacks downgraded shares of Cynosure from an “outperform” rating to a “neutral” rating in a research note on Tuesday, December 31st. They now have a $28.70 price target on the stock. Finally, analysts at R. F. Lafferty initiated coverage on shares of Cynosure in a research note on Tuesday, December 10th. They set a “buy” rating and a $34.00 price target on the stock. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The stock has an average rating of “Buy” and an average price target of $34.93.
Cynosure (NASDAQ:CYNO) traded down 1.46% during mid-day trading on Friday, hitting $28.97. The stock had a trading volume of 96,844 shares. Cynosure has a one year low of $21.09 and a one year high of $30.20. The stock’s 50-day moving average is $26.71 and its 200-day moving average is $24.62. The company’s market cap is $648.8 million.
Cynosure (NASDAQ:CYNO) last announced its earnings results on Wednesday, February 12th. The company reported $0.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.19 by $0.20. The company had revenue of $74.50 million for the quarter, compared to the consensus estimate of $67.80 million. During the same quarter in the previous year, the company posted $0.27 earnings per share. The company’s revenue for the quarter was up 74.5% on a year-over-year basis. On average, analysts predict that Cynosure will post $1.36 earnings per share for the current fiscal year.
Cynosure Inc (NASDAQ:CYNO), develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair rejuvenate the skin through the treatment of vascular and pigmented lesions, remove multi-colored tattoos, liquefy and remove unwanted fat through laser lypolysis, reduce cellulite and treat onychomycosis.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.